Related Experiment Video
Updated: May 12, 2026
11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Metabolomics in chronic kidney disease
1Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, the College of Life Sciences, Northwest University, Xi'an, Shaanxi 710069, PR China. zyy@nwu.edu.cn
Summary
Metabolomics offers new hope for early chronic kidney disease (CKD) detection. This approach identifies novel biomarkers, improving diagnosis and understanding of kidney disease mechanisms beyond traditional tests.
Area of Science:
- Biochemistry
- Nephrology
- Biomarker Discovery
Background:
- Chronic kidney disease (CKD) poses a significant public health burden.
- Current biomarkers (serum creatinine, BUN) lack sensitivity for early CKD detection.
- Need for sensitive biomarkers for early diagnosis and improved therapeutic outcomes.
Purpose of the Study:
- To review recent advancements in metabolomics.
- To discuss the application of metabolomics in studying various forms of CKD.
- To highlight the potential of metabolomics for early CKD diagnosis and understanding disease mechanisms.
Main Methods:
- Overview of metabolomic analytical technologies and chemometrics.
- Review of metabolomics in experimental and clinical CKD research.
- Identification and confirmation of metabolic biomarkers for CKD.
Main Results:
- Metabolomics enables non-targeted, global metabolite profiling of biofluids and tissues.
- Several metabolic biomarkers have been identified that detect CKD earlier than traditional methods.
- Metabolomics provides insights into pathophysiological mechanisms of CKD.
Conclusions:
- Metabolomics represents a promising holistic approach for CKD diagnosis and management.
- Identified biomarkers offer improved early detection capabilities for CKD.
- Further research is needed to address challenges and advance metabolomic applications in CKD studies.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...